December 2019

Introducing our first December issue. We include a variety of #pharma and #biotech companies looking to partner, many of which are developing products and technologies for inflammation-based disorders. 

Our editorial features cover partnering deals targeting the inflammation complement cascade and we include a review of the year's high value partnering deals. 

About this edition

Read the full December edition here.